Applied Genetic Technologies Corp. buy melinda
Start price
22.09.17
/
50%
€3.60
Target price
02.10.17
€5.00
Performance (%)
14.58%
End price
02.10.17
€4.13
Summary
This prediction ended on 02.10.17 with a price of €4.13. The BUY prediction by melinda finished with a performance of 14.58%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Applied Genetic Technologies Corp. | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by melinda for this prediction
In the thread Applied Genetic Te. diskutieren
Applied Genetic Technologies Corp. ist ein Biotechnologie - Unternehmen in der klinischen Phase, das in der Entwicklung der Gentherapie Produkte entwickelt , zu transformieren , das Leben von Patienten mit schweren Erkrankungen in der Ophthalmologie eingreift. Die Produkte sind so konzipiert , Retinoschisis mit X verknüpft behandeln
Stopped prediction by melinda for Applied Genetic Technologies Corp.
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€4.00
08.04.19
08.04.19
€5.86
04.11.21
04.11.21
-14.11%
01.07.21
01.07.21
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€2.89
12.01.19
12.01.19
€4.06
22.01.19
22.01.19
-12.81%
22.01.19
22.01.19
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€3.25
22.09.17
22.09.17
€4.51
02.10.17
02.10.17
14.58%
02.10.17
02.10.17